CLINICAL_TRIALS
trial_result
· 2016-03-03
Clinical Trial Update: Androgen Ablation Therapy With or Without Chemotherapy in Treating Patients With Metastatic Prostate Cancer [Phase 3]
Summary
Phase 3 trial comparing androgen ablation therapy with versus without chemotherapy in patients with metastatic hormone-sensitive prostate cancer; results have b…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: ECOG-ACRIN Cancer Research Group | Conditions: Metastatic Hormone-sensitive Prostate Cancer | Phase 3 | Status: COMPLETED | Results posted: 2016-03-03